Long-term outcomes and morbidity after I125 brachytherapy for localised prostate cancer: An early UK series [1]

Clinical Oncology

Volumn 17, Issue 2, 2005, Pages 127-

  Ash, D ^a   Carey, B ^a   Bottomley, D M ^a   Al Qaisieh, B ^a  

^a United Kingdom   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

BRACHYTHERAPY; CANCER GRADING; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; DOSIMETRY; HUMAN; INCONTINENCE; LETTER; LONG TERM CARE; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION INJURY; RECTUM DISEASE; TREATMENT OUTCOME; UNITED KINGDOM;

BRACHYTHERAPY; HUMANS; MALE; MORBIDITY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 14644407466     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.11.002     Document Type: Letter

References (5)

1. P. Iversen F. Rasmussen H.H. Holm Long term results of ultrasonically guided implantation of I125 seeds combined with external radiation in localised prostatic cancer Scand J Urol Nephrol Suppl 138 1991 109-111
2. D.C. Beyer J.B. Priestley Biochemical and disease free survival following iodine 125 prostate implantation Int J Radiat Oncol Biol Phys 37 1997 559-563
3. M.J. Zelefsky T. Hollister A. Raben S. Matthews K. Wallner Five year biochemical outcome on toxicity with transperineal CT planned permanent iodine 125 prostate implantation for patients with localised prostate cancer Int J Radiat Oncol Biol Phys 47 2000 1261-1266
4. H. Ragde A.A. Elgamal P.B. Snow 10 year disease free survival after transperineal sonography guided iodine 125 brachytherapy with or without 45 Gy external beam radiation in the treatment of patients with clinically localised, low to high grade Gleason prostate carcinoma Cancer 83 1998 898-1001
5. D.Y. Gelblum L.L. Potters R. Ashley et al., Urinary morbidity following ultrasound guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys 45 1999 59-67